Assignee
ABIVAX
FR31 patents
Top patents by PatentIndex Score
US9637475B2May 2, 2017
Compounds for treating cancer
ABIVAX13 citations91
US10981874B2Apr 20, 2021
Use of quinoline derivatives for the treatment of inflammatory diseases
ABIVAX5 citations84
US10683284B2Jun 16, 2020
Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging
ABIVAX7 citations83
US10017498B2Jul 10, 2018
Compounds useful for treating AIDS
ABIVAX9 citations83
US9969715B2May 15, 2018
Compounds useful for treating cancer
ABIVAX5 citations83
US10253020B2Apr 9, 2019
Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
ABIVAX8 citations82
US9827237B2Nov 28, 2017
Compounds useful for treating diseases caused by retroviruses
ABIVAX10 citations82
US10435370B2Oct 8, 2019
Quinoline derivatives for the treatment of inflammatory diseases
ABIVAX11 citations81
US10717724B2Jul 21, 2020
Compounds useful for treating cancer
ABIVAX1 citations72
US11649211B2May 16, 2023
Use of quinoline derivatives for the treatment of inflammatory diseases
ABIVAX1 citations70
US10718770B2Jul 21, 2020
Methods for screening compounds for treating or preventing a viral infection or a virus-related condition
ABIVAX4 citations70
US12202804B2Jan 21, 2025
In vitro or ex vivo methods for screening a quinoline derivative
ABIVAX0 citations62
US11649210B2May 16, 2023
Use of quinoline derivatives for the treatment of inflammatory diseases
ABIVAX0 citations62
US11014918B2May 25, 2021
Compounds and pharmaceutical compositions containing at least one of the compounds
ABIVAX0 citations62
US10975063B2Apr 13, 2021
Compound, and production method thereof, and methods of treatment using the compound
ABIVAX0 citations62
US11441181B2Sep 13, 2022
miRNA-124 as a biomarker
ABIVAX1 citations61
US11427566B2Aug 30, 2022
Compounds useful for treating cancer
ABIVAX0 citations61
US12479802B2Nov 25, 2025
Phenyl-n-quinoline derivatives for treating a RNA virus infection
ABIVAX0 citations60
US12421206B2Sep 23, 2025
Aryl-n-aryl derivatives for treating a RNA virus infection
ABIVAX0 citations60
US12247018B2Mar 11, 2025
Aryl-n-aryl derivatives for treating a RNA virus infection
ABIVAX0 citations60
US12084422B2Sep 10, 2024
Phenyl-n-quinoline derivatives for treating a RNA virus infection
ABIVAX1 citations60
US11739073B2Aug 29, 2023
Aryl-n-aryl derivatives for treating a RNA virus infection
ABIVAX0 citations60
US11826372B2Nov 28, 2023
Combinations including ABX196 for the treatment of cancer
ABIVAX0 citations59
US11278552B2Mar 22, 2022
Combinations including ABX196 for the treatment of cancer
ABIVAX0 citations59
US11266667B2Mar 8, 2022
ABX196 for use in the treatment of bladder cancer
ABIVAX0 citations59
US10329317B2Jun 25, 2019
Quinoline derivative for use in the treatment and prevention of viral infections
ABIVAX1 citations59
US10870671B2Dec 22, 2020
Method of preparation of alpha galactosyl ceramides compounds
ABIVAX1 citations58
US11992499B2May 28, 2024
Quinoline derivatives for use in the treatment of inflammation diseases
ABIVAX0 citations52
US10538485B2Jan 21, 2020
Compounds for use as therapeutic agents affecting P53 expression and/or activity
ABIVAX0 citations52
US9556489B2Jan 31, 2017
Use of RBM39 as a biomaker
ABIVAX0 citations46
US10806729B2Oct 20, 2020
Quinoline derivatives for use in the treatment or prevention of viral infection
ABIVAX0 citations39